Comparison of Dexmedetomidine- Ketamin and Fentanyl-Ketamin in analgesia in cystoscopy

Phase 2

Recruiting

• Conditions: cystoscopy.; cystoscopy

• Registration Number: IRCT20141209020258N105
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Both sexes
Age 18 to 65 years old
ASA Class 1 and 2
Cystoscopy candidate
No allergy to used drugs
No history of cardio-pulmonary-liver and kidney disease
Lack of Obstructive Sleep Apnea (OSA)
No history of drug addiction or other psychotropic substances
No history of acute drug or alcohol poisoning
No history of psychological illness

Exclusion Criteria

Dissatisfaction to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of cystoscopy. Timepoint: After intervention. Method of measurement: hours.;Pain. Timepoint: Every 5 minutes to 60 minutes. Method of measurement: Visual analog scale.;Relaxation. Timepoint: Initially and after analgesia, and every 5 minutes during the procedure until 60 minutes later. Method of measurement: Ramsy score.;Satisfaction. Timepoint: After intervention. Method of measurement: questionnaire.;Mean arterial blood pressure. Timepoint: Every 5 minutes after the start of anesthesia until the end of the cystoscopy and during recovery. Method of measurement: mmHg.;Heart rate. Timepoint: Every 5 minutes after the start of anesthesia until the end of the cystoscopy and during recovery. Method of measurement: count.